comparemela.com
Home
Live Updates
Dr Santos on the ADAURA Trial of Adjuvant Osimertinib in EGFR-Mutant NSCLC : comparemela.com
Dr Santos on the ADAURA Trial of Adjuvant Osimertinib in EGFR-Mutant NSCLC
Edgardo S. Santos, MD, FACP, discusses key survival data from the pivotal phase 3 ADAURA trial in early-stage non–small cell lung cancer.
Related Keywords
Florida Atlantic University ,
Florida ,
United States ,
,
Florida Society Of Clinical Oncology ,
Charlese Schmidt College Of Medicine ,
Edgardo Santos ,
Florida Society ,
Clinical Oncology ,
Nsclc ,
Onclive Tv ,
Lung Cancer ,
Kadaura ,
Nct02511106 ,
Osimertinib ,
comparemela.com © 2020. All Rights Reserved.